Universitätsklinikum Freiburg, Zentrum für Kinder und Jugendmedizin Freiburg
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hufnagel, Markus
KIDS-STEP, NCT03474991: _Betamethasone Therapy in Hospitalised Children With CAP

Completed
3
510
Europe
Celestamine®
Julia Bielicki, Swiss National Fund for Scientific Research, University Hospital, Basel, Switzerland
Community-acquired Pneumonia
03/24
03/24
NCT04527380 / 2018-000681-10: A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Active, not recruiting
3
100
Europe, RoW
Ixekizumab, LY2439821, Adalimumab
Eli Lilly and Company
Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis
02/24
04/28
Schramm, Dirk
KIDS-STEP, NCT03474991: _Betamethasone Therapy in Hospitalised Children With CAP

Completed
3
510
Europe
Celestamine®
Julia Bielicki, Swiss National Fund for Scientific Research, University Hospital, Basel, Switzerland
Community-acquired Pneumonia
03/24
03/24
Elling, Robert
KIDS-STEP, NCT03474991: _Betamethasone Therapy in Hospitalised Children With CAP

Completed
3
510
Europe
Celestamine®
Julia Bielicki, Swiss National Fund for Scientific Research, University Hospital, Basel, Switzerland
Community-acquired Pneumonia
03/24
03/24

Download Options